You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pandemic Influenza A Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)

Recruiting
  • Influenza A
  • Pandemic Influenza
  • H7HLAII
  • Oslo, Norway
    Oslo University Hospital
Sep 20, 2023

Influenza, Human Trial in Estonia, Philippines (H5N1 antigen combined with MF59 adjuvant)

Completed
  • Influenza, Human
  • H5N1 antigen combined with MF59 adjuvant
  • Tallinn, Harjumaa, Estonia
  • +6 more
Jul 21, 2022

Influenza, Human Trial in Gentofte, Copenhagen, Hillerød (Vaxigripetra, Flumist)

Not yet recruiting
  • Influenza, Human
  • Vaxigripetra
  • Flumist
  • Gentofte, Copenhagen, Denmark
  • +5 more
Jul 4, 2023

Influenza, Pandemic Trial in Baltimore (BW-1014: 25 µg rH5 in 20% NE - pipette - IN, BW-1014: 50 µg rH5 in 20% NE - pipette -

Recruiting
  • Influenza, Pandemic
  • BW-1014: 25 µg rH5 in 20% NE - pipette - IN
  • +5 more
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, University of
Jul 8, 2022

Influenza Trial in South Jordan (mRNA-1018 for H5N8, mRNA-1018 for H7N9, mRNA-1018 for H5 Only)

Recruiting
  • Influenza
  • mRNA-1018 for H5N8
  • +4 more
  • South Jordan, Utah
    J. Lewis Research, Inc/Jordan River Family Medicine
Jul 25, 2023

Pandemic Influenza Disease Trial in Tampere, München (Placebo (PL), Trivalent influenza virus vaccine (TIV), Adjuvanted

Completed
Has Results
  • Pandemic Influenza Disease
  • Placebo (PL)
  • +3 more
  • Tampere, Finland
  • +1 more
Apr 22, 2021

Pandemic Influenza Trial in United States (A/H5N1, LT Adjuvant Patch)

Completed
Has Results
  • Pandemic Influenza
  • A/H5N1
  • LT Adjuvant Patch
  • Anaheim, California
  • +5 more
Dec 9, 2021

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults

Recruiting
  • Influenza
  • +2 more
  • Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
  • High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Sep 1, 2023

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Vaccination; Infection Trial (Vaccine injection)

Not yet recruiting
  • Vaccination; Infection
  • Vaccine injection
  • (no location specified)
Oct 12, 2023

Influenza Trial in Santiago de Compostela (Influenza vaccine)

Recruiting
  • Influenza
  • Influenza vaccine
  • Santiago de Compostela, A Coruña, Spain
    General Public Health Directorate of Galician Health Service
Nov 15, 2023

Quadrivalent Influenza Vaccine Immunization Schedule for

Completed
  • GCP
  • Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
  • Jinan, Shandong, China
    Kou Zengqiang
Oct 17, 2023

COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)

Recruiting
  • COVID-19
  • +3 more
  • Omicron-containing COVID-19 vaccine
  • influenza vaccine
  • Seoul, Guro-gu, Korea, Republic of
  • +1 more
Oct 17, 2023

Seasonal Influenza and Pneumococcal Vaccination in the Elderly

Recruiting
  • Immunization; Infection
  • +3 more
    • Ankara, Çankaya, Turkey
      Lokman Hekim University
    Dec 22, 2022

    Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

    Not yet recruiting
    • Seasonal Influenza
    • Quadrivalent influenza vaccine(0.25ml)
    • +3 more
    • Lu'an, Anhui, China
    • +4 more
    Sep 15, 2023

    Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

    Completed
    • Influenza
    • +4 more
    • Influenza vaccine [inactivated]
    • Kol'tsovo, Novosibirsk Region, Russian Federation
    • +4 more
    May 11, 2023

    Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)

    Not yet recruiting
    • Influenza
    • TetraFluvac TF vaccine
    • Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
    • Bangkok, Thailand
      Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
    May 30, 2023

    COVID-19 Pandemic Trial in Indonesia, Philippines, Russian Federation (Recombinant SARS-CoV-2 fusion protein vaccine (V-01),

    Active, not recruiting
    • COVID-19 Pandemic
    • Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
    • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
    • Padang, Indonesia
    • +24 more
    Aug 31, 2022

    Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID

    Not yet recruiting
    • Influenza
    • +3 more
    • Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
    • +2 more
    • Phoenix, Arizona
    • +7 more
    Aug 30, 2023

    Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD

    Recruiting
    • Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
    • ExPEC9V
    • +2 more
    • Mechelen, Belgium
      Az Sint-Maarten
    Nov 13, 2023

    Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

    Not yet recruiting
    • Influenza, Human
    • sa-mRNA vaccine Dose 1
    • +4 more
    • (no location specified)
    Sep 7, 2023

    Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated

    Not yet recruiting
    • Immunization; Infection
    • +2 more
    • Standard Dose Quadrivalent Inactivated Influenza Vaccine
    • High Dose Quadrivalent Inactivated Influenza Vaccine
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 11, 2023

    Influenza Trial in Baltimore (H5N1 pISV)

    Completed
    • Influenza
    • H5N1 pISV
    • Baltimore, Maryland
      Center for Immunization Research, Johns Hopkins Bloomberg School
    Feb 15, 2022

    Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

    Not yet recruiting
    • Influenza, Human
    • Quadrivalent Influenza Vaccine (split virion, inactivated)
    • +2 more
    • (no location specified)
    Mar 9, 2023

    Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)

    Not yet recruiting
    • Influenza
    • Quadrivalent influenza virus subunit vaccine
    • Quadrivalent split influenza virus vaccine
    • Taizhou, Jiangsu, China
      Ab&b Biotechnology Co., Ltd.JS
    Jan 12, 2023